In a bold step toward redefining how we age, SRW Laboratories, New Zealand’s frontrunner in biotechnology, has unveiled its latest breakthrough: Cel2 NR. This next-generation supplement, the newest addition to the acclaimed Cel Range, is the result of years of cutting-edge research into the biology of aging. Engineered to support mitochondrial function and boost cellular energy, Cel2 NR marks a significant advancement in the science of nutritional longevity.
The SRW Cel Range was developed, as a science-led solution to support healthy cellular ageing, to improve energy and health span and to address the nine hallmarks of ageing. Each product in the Cel1, Cel2, and Cel3 series was formulated to target various aspects of age-related cellular decline—focusing on genome stability, cellular energy, and tissue integrity. Since its debut, the range has sold over 1 million units worldwide and has built a loyal customer base of 250,000 people worldwide benefiting from their full suite of products. The SRW Cel Range has become a gold standard for consumers seeking proactive, clinically validated longevity solutions.
Always innovating with the latest technology, a new Cel2 NR now launches, with an improved formulation that delivers energy to an entirely new level. Engineered with PlexoZome® Pro NR—a proprietary liposomal delivery system— Cel2 NR boosts the bioavailability of nicotinamide riboside (NR), a key NAD+ precursor, by up to 450%. This significantly enhances the body’s ability to produce NAD+, an essential coenzyme for mitochondrial energy production, DNA repair, and cellular resilience.
The new Cel2 NR is designed for those facing mental and physical fatigue, high- performance individuals seeking sustained vitality, and anyone affected by the modern symptoms of cellular ageing such as brain fog, poor sleep, and slower recovery. Its triple- action formula addresses three of the nine cellular hallmarks of ageing: mitochondrial dysfunction, stem cell exhaustion, and altered intercellular communication.
This new formulation also includes a synergistic blend of advanced ingredients— Astaxanthin, Pterostilbene, Carnosine, Vitamin D3, and Riboflavin (Vitamin B2)—each carefully selected for their roles in mitochondrial support, NAD+ preservation, and oxidative stress reduction alongside Hallmarks of Aging support.
The launch of new Cel2 NR comes on the heels of a landmark clinical trial, published in the Aging Journal, involving 50 US participants – this showed supplementation with Cel1, 2, and 3 over 12 months played a role in reversal of biological age by as much as 5.71 years as measured through DNA methylation ageing clocks. Participants also presented with stronger, leaner bodies, after the 12-month trial.
“The new Cel2 NR represents both a technological advancement and a philosophical one for SRW,” says Founder Greg Macpherson. “It’s the embodiment of our belief that ageing begins in the cell—and so does the solution. We’re not just slowing down ageing. We’re redefining it.”
For more information, visit www.scienceresearchwellness.co
References:
* US Aging Journal Publication: https://www.aging-us.com/article/206221
About SRW Laboratories
SRW Laboratories is a New Zealand-based biotechnology company dedicated to the science of aging well. Founded by health entrepreneur Greg Macpherson, SRW combines cutting-edge research with the world’s most advanced nutraceutical technologies to develop supplements that support cellular health, longevity, and optimal human performance. Collaborating with leading scientists and institutions globally, SRW has developed the innovative Cel Range, a series of evidence-based products targeting the biological hallmarks of aging. With a premium customer base across New Zealand, China, Singapore, and the United States, SRW is at the forefront of the longevity revolution, empowering individuals to live healthier, longer, and more vibrant lives.
